A carregar...

Profile of perampanel and its potential in the treatment of partial onset seizures

Perampanel (PER) is a novel antiepileptic compound that decreases neuronal excitability by modulating glutamatergic transmission through selective noncompetitive blockade of AMPA receptors. PER has been evaluated in three pivotal placebo-controlled randomized trials as adjunctive therapy in adult dr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rheims, Sylvain, Ryvlin, Philippe
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3663472/
https://ncbi.nlm.nih.gov/pubmed/23717043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S30129
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!